-
Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)
(PA-21-232)
National Institute on Minority Health and Health Disparities
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
Office of Research on Women's Health
Application Receipt Date(s): Multiple dates, see announcement.
-
NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)
(PAR-21-217)
National Institute on Aging
Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is August 8, 2021.
-
NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)
(PAR-21-218)
National Institute on Aging
Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is August 8, 2021.
-
NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
(PAR-21-220)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.
-
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
(PAR-21-230)
John E. Fogarty International Center
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Disease Prevention
Application Receipt Date(s): Multiple dates, see announcement.
-
Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed)
(RFA-DA-22-005)
National Institute on Drug Abuse
Application Receipt Date(s): October 14, 2021
-
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed)
(RFA-DA-22-007)
National Institute on Drug Abuse
Application Receipt Date(s): October 14, 2021
-
Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional)
(RFA-DA-22-012)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required)
(RFA-DA-22-024)
National Institute on Drug Abuse
Application Receipt Date(s): October 14, 2021
-
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required)
(RFA-DA-22-030)
National Institute on Drug Abuse
Application Receipt Date(s): October 14, 2021
-
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
(RFA-HL-22-010)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 14, 2021, February 11, 2022, October 13, 2022, February 14, 2023, October 13, 2023, February 13, 2024, by 5:00 PM local time of applicant organization.
All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
(RFA-HL-22-011)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 14, 2021, February 11, 2022, October 13, 2022, February 14, 2023, October 13, 2023, February 13, 2024, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R01 Clinical Trial Optional)
(RFA-MH-21-225)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Not Applicable
-
Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional)
(RFA-MH-21-226)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Not Applicable